Guan X, Wei R, Yang R, et al. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. JAMA Netw Open 2021 Jan 4;4(1):e2031661.
GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery. Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in [...]
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases. Suda K et al. Ann Thorac Surg. 2021 Jan;111(1):269-276.
Cohen R, Taieb J, Fiskum J, et al. Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials. [...]
Commentary: Lung cancer and dysbiosis: Debugging the studies for the future. Pass HI. J Thorac Cardiovasc Surg. 2021 Feb;161(2):430-431.
Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications. Amiri A et al. Curr Med Chem. 2021;28(2):308-328.
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation. Ng TL et al. J Thorac Oncol. 2021 Mar;16(3):486-491.
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. Le X et al. J Thorac Oncol. 2021 Feb;16(2):205-215.
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial. de Gooijer CJ, et al. Lancet Respir Med. 2021 Jan 27:S2213-2600(20)30362-3. [...]
